US 11103479
Small organic molecules for use in the treatment of neuroinflammatory disorders
granted A61KA61K31/165A61K31/345
Quick answer
US patent 11103479 (Small organic molecules for use in the treatment of neuroinflammatory disorders) held by The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center expires Mon Aug 26 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center
- Grant date
- Tue Aug 31 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 26 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K31/165, A61K31/345, A61K31/381, A61K31/395